IQOS Marketing in the US: The Need to Study the Impact of FDA Modified Exposure Authorization, Marketing Distribution Channels, and Potential Targeting of Consumers.

Authors

Carla J. Berg, George Washington University
Lorien C. Abroms, George Washington University
Hagai Levine
Katelyn F. Romm, George Washington University
Amal Khayat
Christina N. Wysota, George Washington University
Zongshuan Duan, George Washington University
Yael Bar-Zeev

Document Type

Journal Article

Publication Date

10-8-2021

Journal

International Journal of Environmental Research and Public Health

Volume

18

Issue

19

DOI

10.3390/ijerph181910551

APA Citation

Berg, C. J., Abroms, L. C., Levine, H., Romm, K. F., Khayat, A., Wysota, C. N., Duan, Z., & Bar-Zeev, Y. (2021). IQOS Marketing in the US: The Need to Study the Impact of FDA Modified Exposure Authorization, Marketing Distribution Channels, and Potential Targeting of Consumers.. International Journal of Environmental Research and Public Health, 18 (19). http://dx.doi.org/10.3390/ijerph181910551

Peer Reviewed

1

Open Access

1